Jennifer Simonson is a business journalist with a decade of experience covering entrepreneurship and small business. Drawing on her background as a founder of multiple startups, she writes for Forbes ...
This activity constitutes Phase 1 of a possible two-part effort directed towards guiding future benefit-cost studies, ensuring greater consistency and comparability across studies, and enhancing the ...
The cost avoidance of heart failure–related hospitalizations and emergency department visits may outweigh the additional drug cost in Medicaid members adherent to sacubitril/valsartan. Objective: To ...
Under the Trump administration, the Securities and Exchange Commission is in the process of revamping its approach to the cost-benefit analysis it performs in support of its regulatory actions. These ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results